au-amc MCQ (SBA): Obesity pharmacotherapy

Instant feedback + full explanation. One question, done properly.

MediumEndocrinologyObesity pharmacotherapyau-amcau-racgpau-racp

A 35-year-old woman with BMI 38 kg/m² and no diabetes asks about medications for weight loss. She has hypertension and dyslipidaemia. According to recent Australian recommendations, which of the following is an evidence-based option for pharmacological weight management in addition to lifestyle modification?

Educational content. Not a substitute for clinical judgement or local policy.

au-amc MCQ: Obesity pharmacotherapy — Answer & Explanation | iatroX